We are evaluating a new CAR-T cell therapy for patients with relapsed or refractory B cell lymphoma. The study aims to assess its safety and effectiveness in treating this condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Non-Hodgkin's lymphoma (NHL) is a type of cancer that originates in the lymphatic system, which is part of the immune system. It includes various subtypes, such as diffuse large B-cell lymphoma and mantle cell lymphoma, and can be aggressive or indolent, affecting how quickly it progresses.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.